We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+4.24%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$308M
AUM Growth
-$65.9M
(-18%)
Cap. Flow
-$69M
Cap. Flow
% of AUM
-22.39%
Top 10 Holdings %
Top 10 Hldgs %
5.18%
Holding
1,028
New
317
Increased
133
Reduced
184
Closed
389
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Matrix Service
MTRX
|
+$1.57M |
| 2 |
ePlus
PLUS
|
+$1.55M |
| 3 |
TOWR
Tower International, Inc.
TOWR
|
+$1.54M |
| 4 |
Insight Enterprises
NSIT
|
+$1.48M |
| 5 |
Astec Industries
ASTE
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$1.91M |
| 2 |
Hovnanian Enterprises
HOV
|
+$1.74M |
| 3 |
RP
RealPage, Inc.
RP
|
+$1.68M |
| 4 |
CBM
Cambrex Corporation
CBM
|
+$1.68M |
| 5 |
ESND
Essendant Inc.
ESND
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Industrials | 15.88% |
| 3 | Consumer Discretionary | 12.74% |
| 4 | Technology | 12.27% |
| 5 | Financials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALE
101
DELISTED
Allete
ALE
| $996K | 0.32% |
14,705
+8,219
| +127% | +$538K |
|
102
Curtiss-Wright
CW
$27.7B
| $990K | 0.32% |
10,853
+8,655
| +394% | +$836K |
|
103
Veracyte
VCYT
$4.52B
| $987K | 0.32% |
107,521
+96,784
| +901% | +$792K |
|
104
CorVel
CRVL
$3.05B
| $971K | 0.32% |
66,993
-1,341
| -2% | -$17.7K |
|
105
ATI
ATI
$27B
| $970K | 0.31% |
+54,007
| New | +$1.02M |
|
106
Vornado Realty Trust
VNO
$7.47B
| $967K | 0.31% |
+11,928
| New | +$1.02M |
|
|
SCLN
107
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $935K | 0.3% |
95,432
-49,143
| -34% | -$491K |
|
|
MYOK
108
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $934K | 0.3% |
+71,059
| New | +$910K |
|
109
Kelly Services Class A
KELYA
$526M
| $932K | 0.3% |
42,640
-4,430
| -9% | -$97.2K |
|
|
ACOR
110
DELISTED
Acorda Therapeutics
ACOR
| $923K | 0.3% |
+366
| New | +$1.05M |
|
111
Century Communities
CCS
$2B
| $913K | 0.3% |
35,949
+23,267
| +183% | +$538K |
|
|
IPHS
112
DELISTED
Innophos Holdings, Inc.
IPHS
| $897K | 0.29% |
16,619
+6,862
| +70% | +$354K |
|
|
PTLA
113
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $886K | 0.29% |
+22,599
| New | +$720K |
|
|
XENT
114
DELISTED
Intersect ENT, Inc
XENT
| $882K | 0.29% |
51,426
+22,024
| +75% | +$308K |
|
115
AngioDynamics
ANGO
$562M
| $874K | 0.28% |
50,373
-8,103
| -14% | -$135K |
|
|
RST
116
DELISTED
ROSETTA STONE INC
RST
| $872K | 0.28% |
89,480
+55,611
| +164% | +$468K |
|
|
ZVO
117
DELISTED
Zovio Inc. Common Stock
ZVO
| $869K | 0.28% |
+81,470
| New | +$834K |
|
|
TRR
118
DELISTED
Trc Companies
TRR
| $868K | 0.28% |
+49,740
| New | +$535K |
|
|
YELL
119
DELISTED
Yellow Corporation Common Stock
YELL
| $864K | 0.28% |
78,452
+31,413
| +67% | +$407K |
|
|
BSTC
120
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $862K | 0.28% |
15,728
-17,145
| -52% | -$908K |
|
|
CUDA
121
DELISTED
Barracuda Networks, Inc.
CUDA
| $859K | 0.28% |
37,182
+26,149
| +237% | +$612K |
|
122
Archrock
AROC
$6.33B
| $858K | 0.28% |
69,172
-84,658
| -55% | -$1.19M |
|
123
Supernus Pharmaceuticals
SUPN
$2.68B
| $854K | 0.28% |
+27,291
| New | +$731K |
|
124
Marcus Corp
MCS
$732M
| $852K | 0.28% |
26,527
+13,302
| +101% | +$411K |
|
125
Akebia Therapeutics
AKBA
$327M
| $836K | 0.27% |
+90,854
| New | +$887K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2017 Portfolio in Review
As of Q1 2017, TFS Capital held 1,028 positions worth $308M, down 18% from $374M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
TFS Capital withdrew a net $69M in Q1 2017, closing 389 positions and reducing 184 holdings. Its most notable exit was Syneos Health, Inc. Class A Common Stock, an estimated $1.91M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Matrix Service worth $1.38M.
- TFS Capital's largest Q1 2017 buy was Matrix Service: 83,646 shares worth $1.38M.
- TFS Capital added most to Taylor Morrison in Q1 2017, an estimated $1.23M increase.
- TFS Capital's biggest Q1 2017 reduction was Enviri, cutting an estimated $1.66M.
- TFS Capital fully exited Syneos Health, Inc. Class A Common Stock in Q1 2017, selling an estimated $1.91M.
- TFS Capital's ten largest holdings make up 5.2% of its $308M portfolio in Q1 2017.
- TFS Capital opened 317 new positions and closed 389 in Q1 2017.
- TFS Capital's portfolio value fell 18% quarter-over-quarter to $308M.
Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.